Reproducibility of non-invasive fibrosis biomarkers, FibroMeter and FibroTest, could be improved by respecting the analytical standardizations

Clinical Biochemistry

Volumn 41, Issue 13, 2008, Pages 1113-1114

  Munteanu, Mona ^a   Imbert Bismut, Françoise ^b   Messous, Djamila ^b   Morra, Rachel ^a   Thabut, Dominique ^b   Lebray, Pascal ^b   Benhamou, Yves ^b   Ratziu, Vlad ^b   Poynard, Thierry ^b  

^a Biopredictive   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

DIAGNOSTIC ACCURACY; INTERMETHOD COMPARISON; LETTER; LIVER FIBROSIS; METHODOLOGY; PRIORITY JOURNAL; REPRODUCIBILITY;

BIOLOGICAL MARKERS; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS;

EID: 49349101901     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.04.020     Document Type: Letter

References (19)

1. Calès P., Veillon P., Konaté A., et al. Reproducibility of blood tests of liver fibrosis in clinical practice. Clin Biochem 41 (2008) 10-18
2. Calès P., Oberti F., Michalak S., et al. Hepatology. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 42 (2005) 1373-1381
3. Halfon P., Bacq Y., De Muret A., et al. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. J Hepatol 46 (2007) 395-402
4. Leroy V., Hilleret M.N., Sturm N., et al. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol 46 (2007) 751-755
5. Ngo Y., Munteanu M., Messous D., et al. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem 52 (2006) 1887-1896
6. Poynard T., Morra R., Halfon P., et al. Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol 15 (2007) 7-40
7. Halfon P., Imbert-Bismut F., Messous D., et al. A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease. Comp Hepatol. 2 (2002) 3-7
8. Imbert-Bismut F., Messous D., Thibault V., et al. Intra-laboratory analytical variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) and reference ranges in healthy blood donors. Clin Chem Lab Med. 42 (2004) 323-333
9. Rosenthal-Allieri M.A., Peritore M.L., Tran A., Halfon P., Benzaken S., and Bernard A. Analytical variability of the FibroTest proteins. Clin Biochem 38 (2005) 473-478
10. Piton A., Messous D., Imbert-Bismut F., et al. [Alpha 2 macroglobulin immunoturbidimetric assays (DakoCytomation reagents) on Roche Diagnostic analysers (Modular P, Cobas Integra). Application to FibroTest-Actic-Test]. Ann. Biol. Clin. 63 (2005) 385-395
11. Imbert-Bismut F., Messous D., Raoult A., et al. Transférabilité des résultats entre les automates RXL, ARX, X-Pand, BN2 (Dade Behring) et le Modular DP (Roche Diagnostics): application aux paramètres des FibroTest et ActiTest. Ann Biol Clin 63 (2005) 305-313
12. Ferard G., Imbert-Bismut F., Messous D., et al. A reference material for traceability of aspartate aminotransferase (AST) results. Clin Chem Lab Med 43 (2005) 549-553
13. Imbert-Bismut F., Messous D., Munteanu M., Morra R., Poynard T., and Hainque B. Standardisation analytique, une nécessite internationale pour homogénéiser les résultats des marqueurs sanguins des lésions histologiques du foie: application aux composants du NASH-Fibrosure. Gastroenterol Clin Biol. (2006) 30 (Abstract)
14. Rosenthal-Allieri M.A., Tran A., Halfon P., et al. Optimal correlation between different instruments for FibroTest-ActiTest protein measurement in patients with chronic hepatitis C. Gastroenterol Clin Biol. 31 (2007) 815-821
15. Vassault A., Grafmeyer D., de Graeve J., Cohen R., Beaudonnet A., and Bienvenu J. Analyses de biologie medicale: specifications et normes d'accéptabilité à l'usage de la validation de techniques. Annales de Biologie Clinique 57 (1999) 685-695
16. www.probioqual.com.
17. www.Biopredictive.com.
18. Imbert-Bismut F., Ratziu V., Pieroni L., Charlotte F., Benhamou Y., Poynard T., and MULTIVIRC Group. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357 (2001) 1069-1075
19. Calès P., Halfon P., Bacq Y., et al. Meta-analysis of blood scores for liver fibrosis in chronic hepatitis C. Hepatology 44 (2006) 279 (Abstract)